APPLICATION
ANDA204696
TYPE
ANDA
ORIGINAL APPROVAL
2017-03-02
LATEST ACTION
2024-02-28
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LINEZOLIDPrescription
LINEZOLID 200MG/100ML (2MG/ML) · SOLUTION · INTRAVENOUS
LINEZOLIDPrescription
LINEZOLID 600MG/300ML (2MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2024-02-28Labeling · Supplement 11 · standardAP
2024-02-28Labeling · Supplement 8 · standardAP
2024-02-28Labeling · Supplement 10 · standardAP
2019-06-28Labeling · Supplement 2 · standardAP
2017-03-02UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.